Therefore, high serum CNOT7 levels are associated with advanced BC stages and hormone receptor status, as presented in Figure S4, which presents significant associations between CNOT7 serum levels (low and high) and clinicopathological variables in BC patients (n = 90). The gene discussed is NR4A1; the disease is breast cancer.